Tag: Wayne Pines

Abrams_Tom.NEWS

11/02/2020

OPDP Director Tom Abrams Retires, Leaving Mark on Drug Promotion Regulation

CHC_DTCadvertisement2

10/16/2018

HHS’ Azar Announces Proposed Rule Requiring DTC Ad Price Disclosures

CHC_FDA-Regulatory Images1

10/04/2018

CDER’s Woodcock Says First Amendment Concerns Dampen OPDP Enforcement

CHC_FDA-Regulatory Images1

07/02/2018

False/Misleading Risk, Efficacy Claims in Online Video Cited in OPDP Enforcement Letter to Pfizer

CHC_FDA-Regulatory Images1

06/14/2018

FDA Final Guidance Documents on Communication Issues Improve Clarity

CHC_DTCadvertisement2

05/21/2018

Debate over Listing Drug Prices in Ads Continues

CHC_DTCadvertisement2

08/11/2017

Limiting Risk Disclosures in DTC Ads Improves Recall of Risk, FDA Study Shows

05/31/2017

Pines: FDA’s Gottlieb Will First Tackle Administrative Issues

CHC_FDA-Regulatory Images1

03/20/2017

Gottlieb Is “Known” Entity to Pharma Industry